Invited editorial: Surgeons at @CleClinicHVTI say internal mammary artery grafting has been the gold standard of coronary revascularization for 40 years and counting. Read in #JTCVS: https://t.co/bOTjGwu7fv
@FaisalBakaeen@AskDrMarc@LarsSvenssonMD
This is a masterful synthesis of the evidence and exceptional analytical insight by a clinically busy surgeon who understands both the science and its application to real-world patient care. Thanks for sharing @VictorDayan1
Interesting pooled analysis of 7 year follow-up in #TAVI - #SAVR trials: all-cause mortality curve for TAVI in low risk patients climbs steeply after 5 years. In patients with 10-15 year expected survival, this shows the importance of long term results
https://t.co/0WSGFLNUYi
@EnochAkowuah1 Very eloquent as usual Enoch! The mortality figures are below. Lines are clearly crossing at 5-6 yrs. The question is seeing that trend, do we wait for a few more years for the p to be come 0.05 or assess critically the guidelines preemptively. https://t.co/6li4pSoOr3